Christine Gispen, MD, PhD

Principal, Gispen4RegulatoryScience

Christine Gispen-de Wied received her MD degree at the University of Groningen. Subsequently she worked as Resident in the Psychiatric Hospital Wolfheze (NL). Thereafter, she joined the field of clinical research at the Department of Psychiatry, University Medical Center Utrecht, UMCU. She received her PhD at Utrecht University, based on her thesis, entitled ‘The Hypothalamo Pituitary Adrenal Axis in Depression’. She was registered as Pharmacologist in 2005. In 2002 she started working for the Medicines Evaluation Board, successively as clinical assessor, Head of the CNS Department, and Head of the Scientific Program and National Scientific Advice. She was a member of the Scientific Advice Working Party, SAWP, and the CNS Working Party at the European Medicines Agency, EMA.

She is member and fellow of the European College of Neuropsychopharmacology, ECNP, and has acted as member of the Consultation Committee for several years to cover topics on drug regulation. In 2016 she started the Regulatory Science Network Netherlands (RSNN) in collaboration with partners of pharmaceutical industry and academia (currently supported by Lygature), to further the field of regulatory science and drug innovation. In 2019, she started her private consultancy Gispen4Regulatory Science. In her private life, she is an active member of Soroptimist International, President of the Sobibor Foundation.